AEGERION PHARMACEUTICALS
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics/pharmaceuticals to treat cardiovascular and metabolic diseases. It develops lomitapide/AEGR-733, a microsomal triglyceride transfer protein inhibitor small molecule drug for decreasing serum lipids, including cholesterol and triglycerides, as well as to treat atherosclerosis, dyslipidemia, obesity, and pancreatitis. The company also focuses on products for the evaluation and treatment of hyperlipidemia. Aegerion Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Bridgewater, New Jersey.
AEGERION PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aegerion.com
Total Employee:
101+
Status:
Active
Contact:
(855) 305-2347
Email Addresses:
[email protected]
Total Funding:
63.68 M USD
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Amazon Virginia Region Amazon Route 53 Smart App Banner OVH
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
BioAtlantis
BioAtlantis is enagaged in the development of nutraceutical ingredients for the plant, human, and animal markets.
Cequent Pharmaceuticals
Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Rinat Neuroscience
A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-11-06 | Myalept | Myalept acquired by Aegerion Pharmaceuticals | N/A |
Investors List
Alta Partners
Alta Partners investment in Convertible Note - Aegerion Pharmaceuticals
Scheer Partners Investments
Scheer Partners Investments investment in Convertible Note - Aegerion Pharmaceuticals
Index Ventures
Index Ventures investment in Convertible Note - Aegerion Pharmaceuticals
Advent International
Advent International investment in Convertible Note - Aegerion Pharmaceuticals
Alta Partners
Alta Partners investment in Series B - Aegerion Pharmaceuticals
Index Ventures
Index Ventures investment in Series B - Aegerion Pharmaceuticals
Advent International
Advent International investment in Series B - Aegerion Pharmaceuticals
Scheer Partners Investments
Scheer Partners Investments investment in Series B - Aegerion Pharmaceuticals
Advent International
Advent International investment in Series A - Aegerion Pharmaceuticals
MVM Life Science Partners
MVM Life Science Partners investment in Series A - Aegerion Pharmaceuticals
Official Site Inspections
http://www.aegerion.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
